Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Cases of Diabetes
4.2.2 Increasing Adoption of Continuous Glucose Monitoring (CGM) Devices
4.3 Market Restraints
4.3.1 Inconsistency of Medicare Reimbursement
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Component
5.1.1 Sensors
5.1.2 Durables (Receivers and Transmitter)
5.2 Geography
5.2.1 North America
5.2.1.1 United States (Value and Volume,2016-2027)
5.2.1.2 Canada (Value and Volume, 2016-2027)
5.2.1.3 Rest of North America (Value and Volume, 2016-2027)
5.2.2 Europe
5.2.2.1 France (Value and Volume, 2016-2027)
5.2.2.2 Germany (Value and Volume, 2016-2027)
5.2.2.3 Italy (Value and Volume, 2016-2027)
5.2.2.4 Spain (Value and Volume, 2016-2027)
5.2.2.5 United Kingdom (Value and Volume, 2016-2027)
5.2.2.6 Russia (Value and Volume, 2016-2027)
5.2.2.7 Rest of Europe (Value and Volume, 2016-2027)
5.2.3 Latin America
5.2.3.1 Mexico (Value and Volume, 2016-2027)
5.2.3.2 Brazil (Value and Volume, 2016-2027)
5.2.3.3 Rest of Latin America (Value and Volume, 2016-2027)
5.2.4 Asia-Pacific
5.2.4.1 Japan (Value and Volume, 2016-2027)
5.2.4.2 South Korea (Value and Volume, 2016-2027)
5.2.4.3 China (Value and Volume, 2016-2027)
5.2.4.4 India (Value and Volume, 2016-2027)
5.2.4.5 Australia (Value and Volume, 2016-2027)
5.2.4.6 Vietnam (Value and Volume, 2016-2027)
5.2.4.7 Malaysia (Value and Volume, 2016-2027)
5.2.4.8 Indonesia (Value and Volume, 2016-2027)
5.2.4.9 Philippines (Value and Volume, 2016-2027)
5.2.4.10 Thailand (Value and Volume, 2016-2027)
5.2.4.11 Rest of Asia-Pacific (Value and Volume, 2016-2027)
5.2.5 Middle-East
5.2.5.1 Saudi Arabia (Value and Volume, 2016-2027)
5.2.5.2 Iran (Value and Volume, 2016-2027)
5.2.5.3 Egypt (Value and Volume, 2016-2027)
5.2.5.4 Oman (Value and Volume, 2016-2027)
5.2.5.5 South Africa (Value and Volume, 2016-2027)
5.2.5.6 Rest of Middle-East (Value and Volume, 2016-2027)


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Dexcom, Inc.
6.1.3 A. Menarini Diagnostics
6.1.4 Echo Therapeutics, Inc.
6.1.5 GlySens Incorporated
6.1.6 Johnson and Johnson
6.1.7 Medtronic Plc
6.1.8 Senseonics Holdings, Inc.
6.1.9 F. Hoffmann-La Roche Ltd
6.1.10 Ypsomed AG
6.1.11 Insulet Corporation
6.1.12 Medtrum Technologies, Inc.
6.1.13 Tandem Diabetes Care
6.1.14 Nemaura Medical, Inc
6.1.15 Texas Instruments Inc
6.2 Company Share Analysis


7 MARKET OPPORTUNITIES AND FUTURE TRENDS